_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
503335426,7/15/2014 20:55:47,,1323836590,7/15/2014 20:55:25,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/15/2014 21:39:50,,1323854545,7/15/2014 21:39:28,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/15/2014 21:46:58,,1323856992,7/15/2014 21:46:29,clixsense,0.6875,19638651,USA,"","",173.23.121.63,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/15/2014 22:43:21,,1323882543,7/15/2014 22:43:12,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,DIABETIC NEUROPATHY causes DIABETES,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/16/2014 01:04:53,,1323959436,7/16/2014 01:04:24,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/16/2014 02:25:56,,1323999639,7/16/2014 02:25:26,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335426,7/16/2014 05:06:15,,1324060067,7/16/2014 05:05:50,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,DIABETES causes DIABETIC NEUROPATHY,0,57,,18,65,causes,1,900359-FS1-4,DIABETIC NEUROPATHY is the most frequent complication of DIABETES and the leading cause of polyneuropathy in the Western world.,DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503335427,7/15/2014 22:42:25,,1323882096,7/15/2014 22:42:19,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 02:45:53,,1324006540,7/16/2014 02:45:17,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,CHRONIC NEUROGENIC BLADDERS diagnosed by PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 07:28:59,,1324106782,7/16/2014 07:28:06,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,CHRONIC NEUROGENIC BLADDERS diagnosed by PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 10:57:04,,1324196371,7/16/2014 10:56:47,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 11:28:38,,1324207113,7/16/2014 11:28:08,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 11:48:02,,1324213850,7/16/2014 11:47:34,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,CHRONIC NEUROGENIC BLADDERS diagnosed by PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335427,7/16/2014 12:32:20,,1324229196,7/16/2014 12:32:13,neodev,0.0,11043386,CAN,"","",162.156.205.17,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE diagnosed by CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,diagnosed by,0.762492851663023,906758-FS1-13,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335428,7/15/2014 21:07:36,,1323841998,7/15/2014 21:07:33,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/15/2014 21:30:33,,1323851615,7/15/2014 21:30:17,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 00:09:19,,1323929250,7/16/2014 00:09:07,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 02:26:36,,1323999907,7/16/2014 02:26:24,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 07:10:31,,1324100868,7/16/2014 07:10:16,instagc,0.6093,18960682,GBR,"","",86.29.147.112,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 07:30:40,,1324107235,7/16/2014 07:30:16,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 10:32:31,,1324185409,7/16/2014 10:31:44,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.872871560943969,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335429,7/15/2014 20:53:24,,1323835701,7/15/2014 20:52:46,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 21:22:12,,1323848104,7/15/2014 21:21:35,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 21:27:23,,1323850383,7/15/2014 21:26:29,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 22:14:39,,1323868615,7/15/2014 22:14:28,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 01:24:34,,1323971657,7/16/2014 01:24:29,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 02:26:04,,1323999681,7/16/2014 02:25:55,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 08:27:35,,1324123773,7/16/2014 08:26:51,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,no_relation,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335430,7/15/2014 21:33:59,,1323852778,7/15/2014 21:33:32,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/15/2014 22:15:15,,1323868909,7/15/2014 22:15:00,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,HEMORRHAGE causes CENTRAL NEUROCYTOMA,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/16/2014 00:09:51,,1323929624,7/16/2014 00:09:23,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,HEMORRHAGE causes CENTRAL NEUROCYTOMA,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/16/2014 02:28:36,,1324000762,7/16/2014 02:28:08,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/16/2014 04:20:56,,1324044557,7/16/2014 04:20:22,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/16/2014 06:16:46,,1324081723,7/16/2014 06:16:28,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335430,7/16/2014 07:29:32,,1324106889,7/16/2014 07:29:01,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,no_relation,40,0,,49,19,causes,0.461880215351701,902535-FS1-4,CENTRAL NEUROCYTOMA seldom present with HEMORRHAGE,HEMORRHAGE,CENTRAL NEUROCYTOMA,RO-disease_may_have_finding
503335431,7/15/2014 21:36:26,,1323853575,7/15/2014 21:36:09,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/15/2014 21:38:40,,1323854275,7/15/2014 21:38:25,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/16/2014 01:24:49,,1323971806,7/16/2014 01:24:42,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/16/2014 09:28:57,,1324148473,7/16/2014 09:28:21,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/16/2014 10:30:21,,1324184726,7/16/2014 10:29:26,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/16/2014 10:57:27,,1324196461,7/16/2014 10:57:06,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,HEROIN USE causes HEROIN DEPENDENCE,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335431,7/16/2014 11:28:06,,1324206946,7/16/2014 11:27:14,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,108,40,,117,57,causes,0.979957887012223,903579-FS1-4,"No major differences in the severity of HEROIN DEPENDENCE were detected among users with 5 or more years of HEROIN USE (long term users), but differences were found among newer users (SDS mean scores, 7.3 in heroin injectors; 7.9 in smokers and 4.6 in sniffers; P = 0.006), especially those with fewer than 3 years of use.",HEROIN USE,HEROIN DEPENDENCE,RO-has_causative_agent
503335432,7/15/2014 21:40:35,,1323854845,7/15/2014 21:40:10,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,HYDROCEPHALUS causes ATROPHIC BRAIN,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/15/2014 21:58:26,,1323861194,7/15/2014 21:57:36,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,HYDROCEPHALUS causes ATROPHIC BRAIN,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/15/2014 22:26:58,,1323874347,7/15/2014 22:26:39,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,ATROPHIC BRAIN causes HYDROCEPHALUS,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/16/2014 00:09:19,,1323929251,7/16/2014 00:09:07,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,ATROPHIC BRAIN causes HYDROCEPHALUS,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/16/2014 02:26:23,,1323999807,7/16/2014 02:26:14,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,ATROPHIC BRAIN causes HYDROCEPHALUS,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/16/2014 05:04:56,,1324059585,7/16/2014 05:04:20,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335432,7/16/2014 06:16:46,,1324081720,7/16/2014 06:16:28,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,20,47,,33,60,causes,0.884651736929383,902065-FS1-4,With respect to the ATROPHIC BRAIN in cases of HYDROCEPHALUS the fronto nasal approach appeared to be the best and less traumatic way of exposing the frontal base of the skull.,ATROPHIC BRAIN,HYDROCEPHALUS,RO-disease_has_primary_anatomic_site
503335433,7/15/2014 20:57:00,,1323837050,7/15/2014 20:56:30,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,PRIMARY HEADACHE CONDITIONS causes CLUSTER HEADACHE,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:14:51,,1323845178,7/15/2014 21:14:28,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:47:20,,1323857108,7/15/2014 21:46:59,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:59:17,,1323861674,7/15/2014 21:58:27,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,CLUSTER HEADACHE causes PRIMARY HEADACHE CONDITIONS,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 22:14:27,,1323868513,7/15/2014 22:14:07,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,CLUSTER HEADACHE causes PRIMARY HEADACHE CONDITIONS,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/16/2014 01:04:23,,1323959141,7/16/2014 01:03:19,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/16/2014 04:21:30,,1324044720,7/16/2014 04:20:57,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335434,7/15/2014 21:06:22,,1323841496,7/15/2014 21:05:40,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/15/2014 21:57:02,,1323860599,7/15/2014 21:56:21,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 00:40:05,,1323945877,7/16/2014 00:39:20,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 01:07:14,,1323960782,7/16/2014 01:06:47,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,no_relation,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 02:26:04,,1323999676,7/16/2014 02:25:55,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 02:28:05,,1324000476,7/16/2014 02:27:34,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 04:21:30,,1324044721,7/16/2014 04:20:57,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,16,71,,56,77,causes,0.377964473009227,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335435,7/15/2014 21:22:55,,1323848446,7/15/2014 21:22:38,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,ACUTE CONTACT DERMATITIS causes SKIN,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/15/2014 21:38:40,,1323854263,7/15/2014 21:38:25,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/15/2014 21:47:20,,1323857121,7/15/2014 21:46:59,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/15/2014 21:58:26,,1323861195,7/15/2014 21:57:36,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,ACUTE CONTACT DERMATITIS causes SKIN,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/15/2014 22:02:16,,1323863098,7/15/2014 22:01:26,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/16/2014 00:33:17,,1323942669,7/16/2014 00:32:53,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335435,7/16/2014 01:57:39,,1323985113,7/16/2014 01:56:50,neodev,0.6071,22474709,USA,NY,Tonawanda,108.17.6.163,no_relation,66,4,,69,28,causes,0.488677777425221,905031-FS1-4,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335436,7/15/2014 20:52:46,,1323835520,7/15/2014 20:52:22,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/15/2014 21:24:30,,1323849133,7/15/2014 21:23:50,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,TIMOLOL causes MYOCARDIAL INFARCTION,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/15/2014 21:30:47,,1323851684,7/15/2014 21:30:33,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,no_relation,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/15/2014 23:29:47,,1323907504,7/15/2014 23:29:04,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/16/2014 01:38:45,,1323977909,7/16/2014 01:38:14,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,TIMOLOL causes MYOCARDIAL INFARCTION,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/16/2014 02:19:46,,1323997110,7/16/2014 02:19:18,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,MYOCARDIAL INFARCTION causes TIMOLOL,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335436,7/16/2014 02:55:02,,1324009324,7/16/2014 02:54:16,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,49,35,,69,42,causes,0.5,907627-FS1-4,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335437,7/15/2014 20:57:15,,1323837131,7/15/2014 20:57:02,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/15/2014 21:46:27,,1323856818,7/15/2014 21:45:53,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 00:10:32,,1323930139,7/16/2014 00:09:58,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,SEIZURES causes EPILEPSY,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 00:38:38,,1323945155,7/16/2014 00:37:59,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 02:25:54,,1323999607,7/16/2014 02:25:43,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 02:47:31,,1324007039,7/16/2014 02:46:51,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 06:16:00,,1324081369,7/16/2014 06:15:41,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,SEIZURES causes EPILEPSY,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335438,7/15/2014 21:07:07,,1323841812,7/15/2014 21:06:23,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/15/2014 22:38:33,,1323880324,7/15/2014 22:38:03,instagc,0.6089,13763729,USA,"","",75.182.89.225,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/16/2014 02:54:15,,1324009094,7/16/2014 02:53:38,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/16/2014 06:16:00,,1324081368,7/16/2014 06:15:41,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/16/2014 06:19:05,,1324082535,7/16/2014 06:18:35,neodev,0.7083,28336203,USA,PA,Harrisburg,50.149.53.150,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/16/2014 08:07:00,,1324117514,7/16/2014 08:06:31,instagc,0.6736,20183814,USA,"","",166.182.83.84,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335438,7/16/2014 08:34:36,,1324125552,7/16/2014 08:33:55,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,CUSHING'S SYNDROME diagnosed by METYRAPONE TESTING TESTING,26,121,,43,147,diagnosed by,1,906876-FS1-13,"Differential diagnosis of CUSHING'S SYNDROME involves: plasma ACTH level determination, high dose dexamethasone testing, METYRAPONE TESTING TESTING with CRH, testing with vasopressin or combination, and finally, bilateral simultaneous petrosal sinus sampling with CRH stimulation.",CUSHING'S SYNDROME,METYRAPONE TESTING TESTING,RO-may_diagnose
503335439,7/15/2014 21:06:45,,1323841683,7/15/2014 21:06:37,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,CHRONIC NEUROGENIC BLADDERS treats PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:18:59,,1323846805,7/15/2014 21:18:44,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:27:23,,1323850387,7/15/2014 21:26:40,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:59:33,,1323861821,7/15/2014 21:58:36,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,CHRONIC NEUROGENIC BLADDERS treats PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 01:33:39,,1323975945,7/16/2014 01:33:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 01:39:56,,1323978348,7/16/2014 01:39:37,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 05:41:05,,1324070540,7/16/2014 05:40:23,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335440,7/15/2014 21:06:57,,1323841771,7/15/2014 21:06:46,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,HAEMATURIA causes CARCINOMA OF THE BLADDER,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/15/2014 21:22:12,,1323848100,7/15/2014 21:21:35,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,HAEMATURIA causes CARCINOMA OF THE BLADDER,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/15/2014 22:38:02,,1323880013,7/15/2014 22:37:30,instagc,0.6089,13763729,USA,"","",75.182.89.225,CARCINOMA OF THE BLADDER causes HAEMATURIA,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/16/2014 01:25:04,,1323972054,7/16/2014 01:24:57,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,HAEMATURIA causes CARCINOMA OF THE BLADDER,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/16/2014 02:53:36,,1324008900,7/16/2014 02:52:48,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,HAEMATURIA causes CARCINOMA OF THE BLADDER,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/16/2014 06:17:11,,1324081892,7/16/2014 06:16:47,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,CARCINOMA OF THE BLADDER causes HAEMATURIA,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335440,7/16/2014 08:06:29,,1324117331,7/16/2014 08:05:53,instagc,0.6736,20183814,USA,"","",166.182.83.84,CARCINOMA OF THE BLADDER causes HAEMATURIA,222,91,,231,115,causes,0.341881729378914,902786-FS1-4,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335441,7/16/2014 05:08:20,,1324060833,7/16/2014 05:07:43,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 08:27:35,,1324123774,7/16/2014 08:26:51,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 09:16:22,,1324137926,7/16/2014 09:15:25,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 09:31:38,,1324149860,7/16/2014 09:31:00,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 10:35:05,,1324186244,7/16/2014 10:34:39,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 10:55:07,,1324195633,7/16/2014 10:54:45,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,KIDNEYS is location of RENAL CELL CARCINOMA,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335441,7/16/2014 11:29:39,,1324207463,7/16/2014 11:29:12,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,71,15,,77,35,is location of,0.948683298050514,902457-FS1-9,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335442,7/15/2014 21:06:45,,1323841684,7/15/2014 21:06:37,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 21:35:28,,1323853233,7/15/2014 21:34:56,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 22:09:31,,1323866375,7/15/2014 22:08:58,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 22:39:23,,1323880718,7/15/2014 22:38:58,instagc,0.6089,13763729,USA,"","",75.182.89.225,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 00:39:19,,1323945501,7/16/2014 00:38:40,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 01:07:14,,1323960785,7/16/2014 01:06:47,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 02:17:59,,1323996315,7/16/2014 02:17:45,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS treats EXTRACTION OF BOTH LENSES,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335443,7/15/2014 20:56:29,,1323836850,7/15/2014 20:55:28,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/15/2014 21:25:47,,1323849688,7/15/2014 21:25:08,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/15/2014 21:59:17,,1323861669,7/15/2014 21:58:27,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/15/2014 22:01:24,,1323862758,7/15/2014 22:00:35,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/15/2014 23:32:08,,1323908824,7/15/2014 23:31:45,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/16/2014 00:40:40,,1323946114,7/16/2014 00:40:07,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335443,7/16/2014 02:20:05,,1323997229,7/16/2014 02:19:48,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,CREAM VERSUS ORAL METRONIDAZOLE treats BACTERIAL VAGINOSIS,109,57,,127,88,treats,0.988371697650617,907603-FS1-2,"Andres FJ, Parker R, Hosein I et al. Clindamycin vaginal CREAM VERSUS ORAL METRONIDAZOLE in the treatment of BACTERIAL VAGINOSIS: a prospective double blind clinical trial.",BACTERIAL VAGINOSIS,CREAM VERSUS ORAL METRONIDAZOLE,RO-may_treat
503335444,7/15/2014 22:09:59,,1323866606,7/15/2014 22:09:32,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/15/2014 22:43:11,,1323882464,7/15/2014 22:42:58,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/16/2014 00:37:58,,1323944858,7/16/2014 00:37:26,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/16/2014 01:04:53,,1323959438,7/16/2014 01:04:24,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/16/2014 09:30:59,,1324149471,7/16/2014 09:30:27,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/16/2014 10:29:23,,1324184341,7/16/2014 10:28:34,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335444,7/16/2014 10:54:45,,1324195564,7/16/2014 10:54:12,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,CISPLATINUM treats OSTEOSARCOMA,19,50,,30,61,treats,0.995037190209989,908101-FS1-2,Nine patients with OSTEOSARCOMA were treated with CISPLATINUM and high dose methotrexate therapy.,OSTEOSARCOMA,CISPLATINUM,RO-may_treat
503335445,7/15/2014 21:04:44,,1323840720,7/15/2014 21:04:11,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/15/2014 22:08:57,,1323866133,7/15/2014 22:08:17,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 01:24:41,,1323971710,7/16/2014 01:24:35,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 02:18:04,,1323996352,7/16/2014 02:18:00,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 10:54:45,,1324195565,7/16/2014 10:54:12,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 11:29:39,,1324207464,7/16/2014 11:29:12,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 11:47:32,,1324213622,7/16/2014 11:46:52,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335446,7/15/2014 21:01:48,,1323839339,7/15/2014 21:01:41,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,ACQUIRED IMMUNE DEFICIENCY SYNDROME causes HUMAN IMMUNODEFICIENCY VIRUS (HIV),30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/15/2014 21:26:13,,1323849885,7/15/2014 21:25:48,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/15/2014 21:46:27,,1323856817,7/15/2014 21:45:53,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:17:44,,1323996181,7/16/2014 02:17:40,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:27:29,,1324000210,7/16/2014 02:26:42,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:48:54,,1324007524,7/16/2014 02:48:21,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 04:22:19,,1324044965,7/16/2014 04:21:54,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,30,88,,63,123,causes,0.976187060183953,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335447,7/15/2014 21:07:32,,1323841952,7/15/2014 21:07:28,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,SEPSIS treats GENTAMYCIN,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 00:32:26,,1323942295,7/16/2014 00:31:38,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 01:33:39,,1323975936,7/16/2014 01:33:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 02:26:13,,1323999729,7/16/2014 02:26:05,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 02:47:25,,1324007005,7/16/2014 02:46:59,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 05:04:19,,1324059390,7/16/2014 05:03:11,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335447,7/16/2014 05:43:02,,1324071051,7/16/2014 05:42:41,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,GENTAMYCIN treats SEPSIS,285,62,,290,72,treats,0.981980506061966,908225-FS1-2,Conclusions are that (i) therapeutic doses of indomethacin or GENTAMYCIN clearly improved the survival in a clinically relevant rat sepsis model; (ii) the exact mechanism of protection with indomethacin is unknown; and (iii) indomethacin should be considered for use in human clinical SEPSIS.,SEPSIS,GENTAMYCIN,RO-may_treat
503335448,7/15/2014 21:39:50,,1323854547,7/15/2014 21:39:28,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 00:40:40,,1323946115,7/16/2014 00:40:07,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 02:26:23,,1323999806,7/16/2014 02:26:14,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 02:51:57,,1324008364,7/16/2014 02:51:23,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 07:51:22,,1324112516,7/16/2014 07:50:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 09:30:26,,1324149234,7/16/2014 09:29:30,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335448,7/16/2014 10:57:27,,1324196455,7/16/2014 10:57:06,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,87,16,,133,53,causes,0.308606699924184,900459-FS1-4,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335449,7/15/2014 21:07:23,,1323841893,7/15/2014 21:07:19,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 02:21:21,,1323997714,7/16/2014 02:20:23,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 02:46:23,,1324006682,7/16/2014 02:45:57,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 05:04:56,,1324059586,7/16/2014 05:04:20,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 05:42:06,,1324070808,7/16/2014 05:41:44,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 07:52:12,,1324112797,7/16/2014 07:51:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 08:07:45,,1324117704,7/16/2014 08:07:34,instagc,0.6736,20183814,USA,"","",166.182.83.84,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.872871560943969,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335450,7/15/2014 21:23:37,,1323848768,7/15/2014 21:23:15,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,VIRUS diagnosed by PROOF OF A VIRAL INFECTION OF SHML,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/15/2014 21:26:13,,1323849884,7/15/2014 21:25:48,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,VIRUS diagnosed by PROOF OF A VIRAL INFECTION OF SHML,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/15/2014 22:27:13,,1323874455,7/15/2014 22:27:00,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,VIRUS diagnosed by PROOF OF A VIRAL INFECTION OF SHML,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/16/2014 02:25:42,,1323999570,7/16/2014 02:25:29,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,no_relation,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/16/2014 04:21:53,,1324044844,7/16/2014 04:21:31,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/16/2014 08:28:45,,1324124123,7/16/2014 08:27:37,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,PROOF OF A VIRAL INFECTION OF SHML diagnosed by VIRUS,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335450,7/16/2014 08:35:28,,1324125740,7/16/2014 08:35:02,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,2,57,,6,91,diagnosed by,0.333333333333333,903782-FS1-13,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335451,7/15/2014 20:53:24,,1323835700,7/15/2014 20:52:46,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 20:53:30,,1323835739,7/15/2014 20:53:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:04:44,,1323840721,7/15/2014 21:04:11,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:07:36,,1323841997,7/15/2014 21:07:33,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,RECTAL GLUTEN CHALLENGE diagnosed by GLUTEN SENSITIVITY,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:30:16,,1323851554,7/15/2014 21:29:58,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 22:28:01,,1323874801,7/15/2014 22:27:50,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 22:39:23,,1323880722,7/15/2014 22:38:58,instagc,0.6089,13763729,USA,"","",75.182.89.225,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.970494958830946,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335452,7/15/2014 20:54:39,,1323836167,7/15/2014 20:53:59,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/15/2014 21:25:47,,1323849691,7/15/2014 21:25:08,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/15/2014 22:08:15,,1323865868,7/15/2014 22:07:25,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,PHLEBITIS causes VARICES,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/15/2014 22:13:59,,1323868301,7/15/2014 22:13:55,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,PHLEBITIS causes VARICES,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/16/2014 01:24:28,,1323971595,7/16/2014 01:24:14,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/16/2014 01:33:18,,1323975857,7/16/2014 01:32:58,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,VARICES causes PHLEBITIS,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335452,7/16/2014 02:17:39,,1323996137,7/16/2014 02:17:35,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,no_relation,150,64,,156,73,causes,0.617213399848368,901829-FS1-4,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335453,7/15/2014 21:06:35,,1323841603,7/15/2014 21:06:28,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 01:39:56,,1323978347,7/16/2014 01:39:37,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 06:23:10,,1324083903,7/16/2014 06:22:54,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,PAPAVERINE diagnosed by ERECTILE DYSFUNCTION,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 07:52:12,,1324112800,7/16/2014 07:51:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,no_relation,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 08:26:50,,1324123539,7/16/2014 08:25:46,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 09:04:21,,1324133782,7/16/2014 09:04:16,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 09:17:28,,1324138436,7/16/2014 09:16:23,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.436435780471985,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335454,7/15/2014 20:57:15,,1323837134,7/15/2014 20:57:02,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:01:27,,1323839119,7/15/2014 21:01:19,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:07:14,,1323841843,7/15/2014 21:07:07,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:24:58,,1323849342,7/15/2014 21:24:31,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 22:03:15,,1323863549,7/15/2014 22:02:17,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/16/2014 00:31:36,,1323941910,7/16/2014 00:31:15,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/16/2014 02:20:22,,1323997346,7/16/2014 02:20:06,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335455,7/15/2014 21:02:07,,1323839466,7/15/2014 21:01:59,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,HOST DISEASE (GVHD) PROPHYLAXIS treats MYCOPHENOLATE MOFETIL,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/15/2014 21:07:19,,1323841866,7/15/2014 21:07:15,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,HOST DISEASE (GVHD) PROPHYLAXIS treats MYCOPHENOLATE MOFETIL,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/15/2014 21:30:16,,1323851546,7/15/2014 21:29:58,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,MYCOPHENOLATE MOFETIL treats HOST DISEASE (GVHD) PROPHYLAXIS,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/15/2014 22:10:32,,1323866869,7/15/2014 22:09:59,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,MYCOPHENOLATE MOFETIL treats HOST DISEASE (GVHD) PROPHYLAXIS,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/16/2014 01:31:21,,1323975092,7/16/2014 01:30:35,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,MYCOPHENOLATE MOFETIL treats HOST DISEASE (GVHD) PROPHYLAXIS,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/16/2014 07:30:15,,1324107169,7/16/2014 07:29:34,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,MYCOPHENOLATE MOFETIL treats HOST DISEASE (GVHD) PROPHYLAXIS,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335455,7/16/2014 08:28:45,,1324124124,7/16/2014 08:27:37,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,no_relation,101,37,,131,58,treats,0.949425326555083,907052-FS1-2,"Ciclosporine, alone or combined with MYCOPHENOLATE MOFETIL or methotrexate, was used as graft versus HOST DISEASE (GVHD) PROPHYLAXIS.",HOST DISEASE (GVHD) PROPHYLAXIS,MYCOPHENOLATE MOFETIL,RO-may_prevent
503335456,7/15/2014 20:53:05,,1323835596,7/15/2014 20:52:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/15/2014 21:19:17,,1323846896,7/15/2014 21:19:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/15/2014 22:14:39,,1323868614,7/15/2014 22:14:28,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,MULTIPLE MYELOMA treats MELPHALAN,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/16/2014 06:23:52,,1324084119,7/16/2014 06:23:27,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,MULTIPLE MYELOMA treats MELPHALAN,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/16/2014 08:35:00,,1324125629,7/16/2014 08:34:37,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/16/2014 09:03:49,,1324133616,7/16/2014 09:03:42,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335456,7/16/2014 10:30:41,,1324184825,7/16/2014 10:30:11,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.991836598134176,908204-FS1-2,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503335457,7/15/2014 20:53:58,,1323835861,7/15/2014 20:53:25,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 20:55:03,,1323836315,7/15/2014 20:54:43,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 21:31:32,,1323852000,7/15/2014 21:31:12,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 21:39:03,,1323854412,7/15/2014 21:38:41,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 22:42:25,,1323882093,7/15/2014 22:42:19,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 23:31:43,,1323908590,7/15/2014 23:30:47,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/16/2014 01:24:49,,1323971856,7/16/2014 01:24:42,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335458,7/15/2014 20:54:32,,1323836089,7/15/2014 20:54:01,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/15/2014 21:31:32,,1323851993,7/15/2014 21:31:12,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 05:40:22,,1324070332,7/16/2014 05:39:38,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 06:17:11,,1324081893,7/16/2014 06:16:47,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 07:10:15,,1324100760,7/16/2014 07:09:58,instagc,0.6093,18960682,GBR,"","",86.29.147.112,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 08:34:36,,1324125553,7/16/2014 08:33:55,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 09:29:29,,1324148817,7/16/2014 09:28:58,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335459,7/15/2014 21:36:08,,1323853473,7/15/2014 21:35:29,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/15/2014 22:27:49,,1323874664,7/15/2014 22:27:35,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 00:38:38,,1323945156,7/16/2014 00:37:59,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 01:33:18,,1323975864,7/16/2014 01:32:58,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,no_relation,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 07:11:11,,1324101113,7/16/2014 07:10:57,instagc,0.6093,18960682,GBR,"","",86.29.147.112,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 08:05:51,,1324117161,7/16/2014 08:05:12,instagc,0.6736,20183814,USA,"","",166.182.83.84,no_relation,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 08:25:44,,1324123189,7/16/2014 08:24:41,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335460,7/15/2014 20:52:46,,1323835510,7/15/2014 20:52:22,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,MERCURY EXPOSURE causes MERCURY TOXICITY,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/15/2014 21:19:39,,1323847003,7/15/2014 21:19:18,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,MERCURY EXPOSURE causes MERCURY TOXICITY,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/15/2014 21:21:05,,1323847571,7/15/2014 21:20:39,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,MERCURY TOXICITY causes MERCURY EXPOSURE,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/16/2014 06:23:27,,1324083973,7/16/2014 06:23:10,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,MERCURY TOXICITY causes MERCURY EXPOSURE,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/16/2014 10:30:21,,1324184714,7/16/2014 10:29:26,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,MERCURY EXPOSURE causes MERCURY TOXICITY,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/16/2014 10:30:41,,1324184823,7/16/2014 10:30:11,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,no_relation,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335460,7/16/2014 10:57:04,,1324196372,7/16/2014 10:56:47,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,MERCURY EXPOSURE causes MERCURY TOXICITY,160,129,,175,145,causes,0.881917103688197,903593-FS1-4,"Although toxic effects of mercury were not demonstrated at these levels of exposure, children of mercury workers are at risk for MERCURY EXPOSURE and potential MERCURY TOXICITY.",MERCURY TOXICITY,MERCURY EXPOSURE,RO-has_causative_agent
503335461,7/15/2014 21:22:46,,1323848347,7/15/2014 21:22:13,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,LYMPH VESSELS causes LYMPHANGIOMA,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/15/2014 22:28:01,,1323874796,7/15/2014 22:27:50,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,LYMPH VESSELS causes LYMPHANGIOMA,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/15/2014 22:42:17,,1323882037,7/15/2014 22:41:59,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,LYMPH VESSELS causes LYMPHANGIOMA,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/16/2014 02:48:15,,1324007280,7/16/2014 02:47:30,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,LYMPH VESSELS causes LYMPHANGIOMA,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/16/2014 07:10:31,,1324100867,7/16/2014 07:10:16,instagc,0.6093,18960682,GBR,"","",86.29.147.112,no_relation,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/16/2014 07:30:40,,1324107236,7/16/2014 07:30:16,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,no_relation,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335461,7/16/2014 07:51:41,,1324112622,7/16/2014 07:51:23,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,LYMPH VESSELS causes LYMPHANGIOMA,99,20,,111,32,causes,0.436435780471985,902202-FS1-4,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335462,7/15/2014 21:00:17,,1323838537,7/15/2014 20:59:23,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,ADENOPATHY causes INFECTIOUS MONONUCLEOSIS,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 21:07:53,,1323842134,7/15/2014 21:07:08,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,INFECTIOUS MONONUCLEOSIS causes ADENOPATHY,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 21:19:17,,1323846897,7/15/2014 21:19:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,INFECTIOUS MONONUCLEOSIS causes ADENOPATHY,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 21:24:24,,1323849087,7/15/2014 21:24:05,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,INFECTIOUS MONONUCLEOSIS causes ADENOPATHY,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 21:34:53,,1323853039,7/15/2014 21:34:00,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,INFECTIOUS MONONUCLEOSIS causes ADENOPATHY,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 21:58:35,,1323861274,7/15/2014 21:57:38,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335462,7/15/2014 23:30:21,,1323907837,7/15/2014 23:29:49,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,INFECTIOUS MONONUCLEOSIS causes ADENOPATHY,34,53,,43,77,causes,0.977355554850442,901789-FS1-4,Prodromal sore throat and diffuse ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS rather than viral hepatitis.,ADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503335463,7/15/2014 20:54:00,,1323835864,7/15/2014 20:53:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 00:32:51,,1323942454,7/16/2014 00:32:28,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 00:35:50,,1323944042,7/16/2014 00:34:50,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 01:39:06,,1323978049,7/16/2014 01:38:46,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,DELAYED TYPE HYPERSENSITIVITY LESIONS diagnosed by EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 02:17:59,,1323996313,7/16/2014 02:17:45,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,DELAYED TYPE HYPERSENSITIVITY LESIONS diagnosed by EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 06:23:52,,1324084118,7/16/2014 06:23:27,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,DELAYED TYPE HYPERSENSITIVITY LESIONS diagnosed by EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335463,7/16/2014 07:10:15,,1324100761,7/16/2014 07:09:58,instagc,0.6093,18960682,GBR,"","",86.29.147.112,no_relation,87,16,,133,53,diagnosed by,0.308606699924184,900459-FS1-13,Their number in DELAYED TYPE HYPERSENSITIVITY LESIONS was significantly higher than in EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS.,EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS LESIONS,DELAYED TYPE HYPERSENSITIVITY LESIONS,RO-cause_of
503335464,7/15/2014 22:42:17,,1323882036,7/15/2014 22:41:59,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 00:39:19,,1323945502,7/16/2014 00:38:40,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,HAEMATURIA diagnosed by CARCINOMA OF THE BLADDER,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 02:17:29,,1323996030,7/16/2014 02:16:55,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,HAEMATURIA diagnosed by CARCINOMA OF THE BLADDER,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 10:30:10,,1324184650,7/16/2014 10:29:24,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 10:34:07,,1324185941,7/16/2014 10:33:19,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 11:30:59,,1324207886,7/16/2014 11:29:42,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 11:47:32,,1324213621,7/16/2014 11:46:52,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335465,7/15/2014 21:05:39,,1323841146,7/15/2014 21:04:47,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,NICKEL ALLERGY causes DELAYED TYPE HYPERSENSITIVITY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/15/2014 21:18:59,,1323846804,7/15/2014 21:18:44,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,NICKEL ALLERGY causes DELAYED TYPE HYPERSENSITIVITY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/15/2014 21:39:27,,1323854487,7/15/2014 21:39:04,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,DELAYED TYPE HYPERSENSITIVITY causes NICKEL ALLERGY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/15/2014 23:32:08,,1323908822,7/15/2014 23:31:45,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,DELAYED TYPE HYPERSENSITIVITY causes NICKEL ALLERGY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/16/2014 00:37:58,,1323944857,7/16/2014 00:37:26,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,NICKEL ALLERGY causes DELAYED TYPE HYPERSENSITIVITY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/16/2014 05:40:22,,1324070336,7/16/2014 05:39:38,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,NICKEL ALLERGY causes DELAYED TYPE HYPERSENSITIVITY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335465,7/16/2014 07:09:57,,1324100600,7/16/2014 07:09:40,instagc,0.6093,18960682,GBR,"","",86.29.147.112,DELAYED TYPE HYPERSENSITIVITY causes NICKEL ALLERGY,0,68,,13,97,causes,0.997054485501582,900186-FS1-4,NICKEL ALLERGY is manifested as contact allergic eczema elicited by DELAYED TYPE HYPERSENSITIVITY the reaction being mediated by T lymphocytes.,NICKEL ALLERGY,DELAYED TYPE HYPERSENSITIVITY,RO-cause_of
503335466,7/15/2014 21:18:57,,1323846802,7/15/2014 21:18:41,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/15/2014 21:26:27,,1323850023,7/15/2014 21:25:36,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/15/2014 22:42:41,,1323882241,7/15/2014 22:42:27,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/15/2014 23:30:46,,1323908037,7/15/2014 23:30:23,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/16/2014 04:20:56,,1324044558,7/16/2014 04:20:22,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/16/2014 05:41:43,,1324070715,7/16/2014 05:41:06,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,RENAL CELL CARCINOMA causes KIDNEYS,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335466,7/16/2014 07:52:59,,1324113023,7/16/2014 07:52:34,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,KIDNEYS causes RENAL CELL CARCINOMA,71,15,,77,35,causes,0.316227766016838,902457-FS1-4,Posttransplant RENAL CELL CARCINOMA (RCC) usually arises in the native KIDNEYS of renal transplant recipients rather than in the transplanted kidney.,KIDNEYS,RENAL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503335467,7/15/2014 21:07:07,,1323841813,7/15/2014 21:06:23,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/15/2014 22:42:57,,1323882357,7/15/2014 22:42:42,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/16/2014 02:26:38,,1323999917,7/16/2014 02:26:01,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/16/2014 05:08:46,,1324061006,7/16/2014 05:08:21,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/16/2014 05:42:39,,1324070948,7/16/2014 05:42:06,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/16/2014 06:15:25,,1324081197,7/16/2014 06:15:02,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335467,7/16/2014 08:08:20,,1324117828,7/16/2014 08:07:45,instagc,0.6736,20183814,USA,"","",166.182.83.84,CROHN'S DISEASE causes SIGMOIDO VESICAL FISTULA,67,113,,90,128,causes,0.970142500145332,906063-FS1-4,We experienced a case of a 16 year old boy with pneumaturia due to SIGMOIDO VESICAL FISTULA as a complication of CROHN'S DISEASE,SIGMOIDO VESICAL FISTULA,CROHN'S DISEASE,RO-has_manifestation
503335468,7/15/2014 22:37:30,,1323879726,7/15/2014 22:37:02,instagc,0.6089,13763729,USA,"","",75.182.89.225,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 01:06:11,,1323960192,7/16/2014 01:05:25,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 01:40:16,,1323978440,7/16/2014 01:39:58,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,STATUS EPILEPTICUS causes SEIZURES,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 02:35:15,,1324003095,7/16/2014 02:34:12,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 08:36:09,,1324125896,7/16/2014 08:35:29,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 09:04:14,,1324133740,7/16/2014 09:04:09,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 09:32:05,,1324150101,7/16/2014 09:31:39,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335469,7/15/2014 21:00:17,,1323838538,7/15/2014 20:59:23,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/15/2014 21:02:07,,1323839467,7/15/2014 21:01:59,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,HYPERTENSIVE CRISIS diagnosed by SECONDARY HYPERTENSION,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/15/2014 21:14:27,,1323845009,7/15/2014 21:14:06,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,HYPERTENSIVE CRISIS diagnosed by SECONDARY HYPERTENSION,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/15/2014 21:20:11,,1323847245,7/15/2014 21:19:40,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/15/2014 22:38:02,,1323880015,7/15/2014 22:37:30,instagc,0.6089,13763729,USA,"","",75.182.89.225,SECONDARY HYPERTENSION diagnosed by HYPERTENSIVE CRISIS,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/16/2014 02:27:29,,1324000211,7/16/2014 02:26:42,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,SECONDARY HYPERTENSION diagnosed by HYPERTENSIVE CRISIS,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335469,7/16/2014 05:08:46,,1324061005,7/16/2014 05:08:21,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,38,3,,59,22,diagnosed by,0.629940788348712,901585-FS1-13,In HYPERTENSIVE CRISIS evaluation for SECONDARY HYPERTENSION should be deferred until the patient is stable.,SECONDARY HYPERTENSION,HYPERTENSIVE CRISIS,RO-disease_has_finding
503335470,7/15/2014 21:06:27,,1323841537,7/15/2014 21:06:16,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,HALOTHANE diagnosed by MALIGNANT HYPERTHERMIA,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/15/2014 21:22:46,,1323848354,7/15/2014 21:22:13,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/15/2014 21:45:20,,1323856473,7/15/2014 21:44:30,clixsense,0.6875,19638651,USA,"","",173.23.121.63,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/16/2014 02:46:23,,1324006681,7/16/2014 02:45:57,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/16/2014 02:52:46,,1324008627,7/16/2014 02:51:59,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/16/2014 05:05:50,,1324059945,7/16/2014 05:04:57,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335470,7/16/2014 08:23:25,,1324122531,7/16/2014 08:22:31,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,71,7,,92,16,diagnosed by,0.990147542976674,906643-FS1-13,By the HALOTHANE test we determined the development of the syndrome of MALIGNANT HYPERTHERMIA in pigs of the Belgian Landrace breed with body weight of 20 kg.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503335471,7/16/2014 00:31:14,,1323941747,7/16/2014 00:30:30,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 02:26:38,,1323999913,7/16/2014 02:26:01,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 09:30:26,,1324149235,7/16/2014 09:29:30,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 10:34:37,,1324186104,7/16/2014 10:34:09,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 10:55:50,,1324195913,7/16/2014 10:55:09,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,EVEN WHEN THE THYROID GLAND IS OUTSIDE OF is location of OF RADIATION INDUCED THYROID CANCER,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 11:28:38,,1324207116,7/16/2014 11:28:08,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335471,7/16/2014 11:48:44,,1324214122,7/16/2014 11:48:03,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,EVEN WHEN THE THYROID GLAND IS OUTSIDE OF is location of OF RADIATION INDUCED THYROID CANCER,121,85,,161,120,is location of,0.514495755427526,902448-FS1-9,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335472,7/15/2014 20:55:47,,1323836588,7/15/2014 20:55:25,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,CHRONIC NEUTROPHILIC LEUKAEMIA causes SPLENOMEGALY,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/15/2014 21:07:28,,1323841937,7/15/2014 21:07:24,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/15/2014 21:13:33,,1323844564,7/15/2014 21:13:12,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/15/2014 21:25:35,,1323849607,7/15/2014 21:24:59,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,CHRONIC NEUTROPHILIC LEUKAEMIA causes SPLENOMEGALY,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/15/2014 21:57:02,,1323860597,7/15/2014 21:56:21,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,CHRONIC NEUTROPHILIC LEUKAEMIA causes SPLENOMEGALY,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/15/2014 22:42:57,,1323882364,7/15/2014 22:42:42,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335472,7/16/2014 05:42:39,,1324070949,7/16/2014 05:42:06,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,SPLENOMEGALY causes CHRONIC NEUTROPHILIC LEUKAEMIA,85,0,,96,30,causes,0.991836598134176,901967-FS1-4,"CHRONIC NEUTROPHILIC LEUKAEMIA is a rare myeloproliferative disease characterised by SPLENOMEGALY sustained neutrophilia, raised vitamin B12 level and absence of the Philadelphia chromosome.",SPLENOMEGALY,CHRONIC NEUTROPHILIC LEUKAEMIA,RO-disease_has_finding
503335473,7/15/2014 20:53:30,,1323835738,7/15/2014 20:53:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/15/2014 21:07:14,,1323841842,7/15/2014 21:07:07,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS treats CYCLOSPORINE,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/15/2014 21:36:08,,1323853475,7/15/2014 21:35:29,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/15/2014 21:40:35,,1323854846,7/15/2014 21:40:10,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/15/2014 22:14:59,,1323868783,7/15/2014 22:14:40,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS treats CYCLOSPORINE,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/16/2014 01:39:36,,1323978172,7/16/2014 01:39:07,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335473,7/16/2014 02:17:44,,1323996182,7/16/2014 02:17:40,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,no_relation,0,117,,43,129,treats,0.371390676354104,907100-FS1-2,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/15/2014 22:13:59,,1323868302,7/15/2014 22:13:55,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS causes CYCLOSPORINE,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/15/2014 22:37:02,,1323879509,7/15/2014 22:36:39,instagc,0.6089,13763729,USA,"","",75.182.89.225,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 10:30:10,,1324184648,7/16/2014 10:29:24,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 10:55:50,,1324195912,7/16/2014 10:55:09,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 11:29:10,,1324207284,7/16/2014 11:28:41,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 11:48:02,,1324213852,7/16/2014 11:47:34,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 12:32:20,,1324229202,7/16/2014 12:32:13,neodev,0.0,11043386,CAN,"","",162.156.205.17,CYCLOSPORINE causes GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335475,7/15/2014 21:01:58,,1323839403,7/15/2014 21:01:50,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:04:39,,1323840693,7/15/2014 21:03:34,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:27:23,,1323850386,7/15/2014 21:26:40,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:31:57,,1323852149,7/15/2014 21:31:34,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:45:20,,1323856468,7/15/2014 21:44:30,clixsense,0.6875,19638651,USA,"","",173.23.121.63,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/16/2014 00:33:32,,1323942787,7/16/2014 00:33:19,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/16/2014 05:41:05,,1324070543,7/16/2014 05:40:23,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,ARREST ARRHYTHMIA treats AGENTS (ATROPINE,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335476,7/15/2014 21:26:27,,1323850015,7/15/2014 21:25:36,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/15/2014 21:59:47,,1323861946,7/15/2014 21:59:17,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/16/2014 06:24:07,,1324084184,7/16/2014 06:23:53,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,EXTRACTION OF BOTH LENSES causes SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/16/2014 07:52:32,,1324112932,7/16/2014 07:52:13,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS causes EXTRACTION OF BOTH LENSES,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/16/2014 09:03:49,,1324133615,7/16/2014 09:03:42,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS causes EXTRACTION OF BOTH LENSES,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/16/2014 09:28:57,,1324148481,7/16/2014 09:28:21,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335476,7/16/2014 10:56:45,,1324196269,7/16/2014 10:55:51,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS causes EXTRACTION OF BOTH LENSES,75,20,,99,64,causes,0.650944554904119,905467-FS1-4,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335477,7/15/2014 20:53:05,,1323835595,7/15/2014 20:52:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/15/2014 21:26:38,,1323850101,7/15/2014 21:26:14,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 00:08:50,,1323928904,7/16/2014 00:08:40,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,OVERT CONGESTIVE HEART FAILURE treats FUROSEMIDE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 01:24:56,,1323971883,7/16/2014 01:24:49,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 01:31:59,,1323975330,7/16/2014 01:31:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 02:18:04,,1323996353,7/16/2014 02:18:00,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,OVERT CONGESTIVE HEART FAILURE treats FUROSEMIDE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 02:45:53,,1324006539,7/16/2014 02:45:17,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335478,7/15/2014 21:01:58,,1323839404,7/15/2014 21:01:50,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,MPS II diagnosed by WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:18:23,,1323846537,7/15/2014 21:18:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:21:05,,1323847570,7/15/2014 21:20:39,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,MPS II diagnosed by WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:22:55,,1323848447,7/15/2014 21:22:38,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 05:42:06,,1324070809,7/16/2014 05:41:44,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 08:08:20,,1324117830,7/16/2014 08:07:45,instagc,0.6736,20183814,USA,"","",166.182.83.84,no_relation,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 08:33:26,,1324125283,7/16/2014 08:32:54,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335479,7/15/2014 20:55:03,,1323836313,7/15/2014 20:54:43,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,DEDIFFERENTIATION treats GLIOBLASTOMA,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/15/2014 21:06:35,,1323841605,7/15/2014 21:06:28,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,DEDIFFERENTIATION treats GLIOBLASTOMA,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/15/2014 21:23:13,,1323848562,7/15/2014 21:22:57,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,DEDIFFERENTIATION treats GLIOBLASTOMA,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/15/2014 21:26:38,,1323850076,7/15/2014 21:26:14,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/15/2014 22:27:13,,1323874456,7/15/2014 22:27:00,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,DEDIFFERENTIATION treats GLIOBLASTOMA,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/16/2014 00:09:03,,1323929028,7/16/2014 00:08:53,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,no_relation,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335479,7/16/2014 00:35:50,,1323944040,7/16/2014 00:34:50,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,DEDIFFERENTIATION treats GLIOBLASTOMA,0,36,,16,48,treats,0.35921060405355,901662-FS1-2,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335480,7/15/2014 21:01:48,,1323839346,7/15/2014 21:01:41,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,MENTAL RETARDATION causes TRISOMY 21,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 00:10:47,,1323930331,7/16/2014 00:10:35,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 05:04:19,,1324059386,7/16/2014 05:03:11,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 07:09:38,,1324100465,7/16/2014 07:09:23,instagc,0.6093,18960682,GBR,"","",86.29.147.112,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 07:51:41,,1324112623,7/16/2014 07:51:23,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 08:23:25,,1324122528,7/16/2014 08:22:31,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335480,7/16/2014 09:04:08,,1324133687,7/16/2014 09:04:02,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,TRISOMY 21 causes MENTAL RETARDATION,62,95,,79,105,causes,0.987878339907213,906118-FS1-4,Down syndrome (DS) is the most frequent genetic disorder with MENTAL RETARDATION and caused by TRISOMY 21,MENTAL RETARDATION,TRISOMY 21,RO-has_manifestation
503335481,7/15/2014 21:06:15,,1323841464,7/15/2014 21:06:01,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/15/2014 21:24:30,,1323849137,7/15/2014 21:23:50,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/15/2014 23:31:43,,1323908571,7/15/2014 23:30:47,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 01:25:04,,1323972055,7/16/2014 01:24:57,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 04:23:01,,1324045167,7/16/2014 04:22:19,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 07:29:32,,1324106900,7/16/2014 07:29:01,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 09:17:28,,1324138437,7/16/2014 09:16:23,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.447213595499958,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335482,7/15/2014 21:13:33,,1323844583,7/15/2014 21:13:12,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:01:24,,1323862759,7/15/2014 22:00:35,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:10:32,,1323866868,7/15/2014 22:09:59,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:38:33,,1323880327,7/15/2014 22:38:03,instagc,0.6089,13763729,USA,"","",75.182.89.225,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 01:06:11,,1323960187,7/16/2014 01:05:25,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 02:17:29,,1323996042,7/16/2014 02:16:55,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,PAIN diagnosed by OSTEOID OSTEOMA,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 02:55:02,,1324009333,7/16/2014 02:54:16,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335483,7/15/2014 21:18:23,,1323846542,7/15/2014 21:18:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 21:57:35,,1323860855,7/15/2014 21:57:03,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 22:08:15,,1323865867,7/15/2014 22:07:25,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,LICHENOID ERUPTION diagnosed by SKIN,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 22:38:57,,1323880526,7/15/2014 22:38:35,instagc,0.6089,13763729,USA,"","",75.182.89.225,SKIN diagnosed by LICHENOID ERUPTION,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 01:39:06,,1323978048,7/16/2014 01:38:46,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,SKIN diagnosed by LICHENOID ERUPTION,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 02:46:54,,1324006855,7/16/2014 02:46:28,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,no_relation,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 02:52:46,,1324008630,7/16/2014 02:51:59,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,32,59,,35,77,diagnosed by,0.548821299948452,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335484,7/15/2014 21:01:40,,1323839266,7/15/2014 21:01:35,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 21:05:59,,1323841278,7/15/2014 21:05:44,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 21:39:27,,1323854489,7/15/2014 21:39:04,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:02:16,,1323863099,7/15/2014 22:01:26,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:14:06,,1323868326,7/15/2014 22:14:00,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:43:11,,1323882465,7/15/2014 22:42:58,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/16/2014 00:32:51,,1323942449,7/16/2014 00:32:28,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335485,7/15/2014 20:55:26,,1323836448,7/15/2014 20:55:05,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 02:25:54,,1323999613,7/16/2014 02:25:43,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 06:15:40,,1324081298,7/16/2014 06:15:26,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 06:24:27,,1324084348,7/16/2014 06:24:09,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 10:35:05,,1324186243,7/16/2014 10:34:39,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 10:55:07,,1324195630,7/16/2014 10:54:45,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335485,7/16/2014 11:30:59,,1324207895,7/16/2014 11:29:42,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,FIBROMYALGIA causes SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,34,11,,83,23,causes,0.997054485501582,904698-FS1-4,"Women with FIBROMYALGIA displayed SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18 tender point locations as defined by the American College of Rheumatology criteria, as well as lower pressure pain thresholds at five control sites.",SIGNIFICANTLY LOWER PRESSURE PAIN THRESHOLDS AT 18,FIBROMYALGIA,RO-has_definitional_manifestation
503335486,7/15/2014 20:55:25,,1323836441,7/15/2014 20:54:41,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,BRONCHIAL HYPERREACTIVITY diagnosed by METHACHOLINE CHLORIDE SOLUTIONS,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/15/2014 21:07:32,,1323841951,7/15/2014 21:07:28,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/15/2014 21:14:51,,1323845181,7/15/2014 21:14:28,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,BRONCHIAL HYPERREACTIVITY diagnosed by METHACHOLINE CHLORIDE SOLUTIONS,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/15/2014 21:18:42,,1323846674,7/15/2014 21:18:24,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/15/2014 22:27:25,,1323874510,7/15/2014 22:27:14,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,METHACHOLINE CHLORIDE SOLUTIONS diagnosed by BRONCHIAL HYPERREACTIVITY,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/16/2014 01:24:56,,1323971912,7/16/2014 01:24:49,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,BRONCHIAL HYPERREACTIVITY diagnosed by METHACHOLINE CHLORIDE SOLUTIONS,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335486,7/16/2014 01:57:39,,1323985110,7/16/2014 01:56:50,neodev,0.6071,22474709,USA,NY,Tonawanda,108.17.6.163,BRONCHIAL HYPERREACTIVITY diagnosed by METHACHOLINE CHLORIDE SOLUTIONS,59,0,,83,31,diagnosed by,1,906521-FS1-13,METHACHOLINE CHLORIDE SOLUTIONS routinely used for testing BRONCHIAL HYPERREACTIVITY have been shown to degrade over time.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE CHLORIDE SOLUTIONS,RO-may_diagnose
503335487,7/15/2014 21:20:00,,1323847143,7/15/2014 21:19:28,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,HEPATITIS B VIRUS causes ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/15/2014 21:30:33,,1323851612,7/15/2014 21:30:17,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,HEPATITIS B VIRUS causes ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/15/2014 22:26:58,,1323874346,7/15/2014 22:26:39,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,HEPATITIS B VIRUS causes ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/15/2014 22:43:21,,1323882542,7/15/2014 22:43:12,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/16/2014 00:09:03,,1323929039,7/16/2014 00:08:53,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,HEPATITIS B VIRUS causes ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/16/2014 01:24:28,,1323971601,7/16/2014 01:24:14,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B causes HEPATITIS B VIRUS,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335487,7/16/2014 02:17:34,,1323996066,7/16/2014 02:17:30,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,HEPATITIS B VIRUS causes ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,85,14,,101,56,causes,1,903602-FS1-4,Hepatitis B e ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B results from infection with HEPATITIS B VIRUS mutants unable to produce HBeAg.,HEPATITIS B VIRUS,ANTIGEN HBEAG NEGATIVE CHRONIC HEPATITIS B,RO-has_causative_agent
503335488,7/15/2014 20:54:00,,1323835855,7/15/2014 20:53:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:07:23,,1323841894,7/15/2014 21:07:19,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:18:57,,1323846788,7/15/2014 21:18:41,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:20:38,,1323847422,7/15/2014 21:20:02,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,GLIOBLASTOMA causes DEDIFFERENTIATION,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 22:37:02,,1323879510,7/15/2014 22:36:39,instagc,0.6089,13763729,USA,"","",75.182.89.225,no_relation,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/16/2014 02:47:25,,1324007006,7/16/2014 02:46:59,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/16/2014 06:22:53,,1324083803,7/16/2014 06:22:39,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,GLIOBLASTOMA causes DEDIFFERENTIATION,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335489,7/15/2014 21:35:28,,1323853228,7/15/2014 21:34:56,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS causes DYSPLASIA,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/15/2014 22:07:24,,1323865388,7/15/2014 22:06:21,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,DYSPLASIA causes 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/15/2014 23:30:46,,1323908035,7/15/2014 23:30:23,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,DYSPLASIA causes 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/16/2014 01:32:32,,1323975559,7/16/2014 01:32:02,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS causes DYSPLASIA,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/16/2014 02:25:56,,1323999640,7/16/2014 02:25:26,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS causes DYSPLASIA,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/16/2014 08:33:53,,1324125400,7/16/2014 08:33:27,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335489,7/16/2014 09:03:55,,1324133636,7/16/2014 09:03:50,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,DYSPLASIA causes 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,51,71,,59,117,causes,0.461880215351701,901611-FS1-4,"Fifty five patients (27.5%) had residual/recurrent DYSPLASIA including 36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (66% 14 low grade squamous intraepithelial lesions (25%), and 5 atypical squamous cells of undetermined significance (9%.",DYSPLASIA,36 HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS,RO-disease_has_finding
503335490,7/15/2014 21:23:48,,1323848862,7/15/2014 21:23:06,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:24:12,,1323849011,7/15/2014 21:23:54,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:36:26,,1323853576,7/15/2014 21:36:09,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:40:09,,1323854711,7/15/2014 21:39:54,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 02:46:54,,1324006856,7/16/2014 02:46:28,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 04:21:53,,1324044843,7/16/2014 04:21:31,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 06:24:27,,1324084357,7/16/2014 06:24:09,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335491,7/15/2014 20:57:00,,1323837051,7/15/2014 20:56:30,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,ECLAMPSIA causes NON LUPUS RELATED PREGNANCY COMPLICATIONS,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/15/2014 21:19:39,,1323847002,7/15/2014 21:19:18,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,NON LUPUS RELATED PREGNANCY COMPLICATIONS causes ECLAMPSIA,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/15/2014 21:31:57,,1323852151,7/15/2014 21:31:34,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,NON LUPUS RELATED PREGNANCY COMPLICATIONS causes ECLAMPSIA,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/15/2014 21:46:58,,1323856991,7/15/2014 21:46:29,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/15/2014 21:56:20,,1323860348,7/15/2014 21:55:41,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,NON LUPUS RELATED PREGNANCY COMPLICATIONS causes ECLAMPSIA,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/16/2014 06:23:27,,1324083972,7/16/2014 06:23:10,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,ECLAMPSIA causes NON LUPUS RELATED PREGNANCY COMPLICATIONS,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335491,7/16/2014 09:04:01,,1324133657,7/16/2014 09:03:56,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,ECLAMPSIA causes NON LUPUS RELATED PREGNANCY COMPLICATIONS,12,78,,52,87,causes,0.787838597158335,901706-FS1-4,"Most common NON LUPUS RELATED PREGNANCY COMPLICATIONS include preeclampsia or ECLAMPSIA hypertension, the HELLP syndrome, and thrombocytopenia.",NON LUPUS RELATED PREGNANCY COMPLICATIONS,ECLAMPSIA,RO-disease_has_finding
503335492,7/15/2014 21:01:40,,1323839265,7/15/2014 21:01:35,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,PHLEBITIS is location of VARICES,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 21:31:11,,1323851837,7/15/2014 21:30:48,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 22:38:57,,1323880525,7/15/2014 22:38:35,instagc,0.6089,13763729,USA,"","",75.182.89.225,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 22:42:41,,1323882237,7/15/2014 22:42:27,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 01:32:32,,1323975558,7/16/2014 01:32:02,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 08:33:26,,1324125284,7/16/2014 08:32:54,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 09:04:08,,1324133689,7/16/2014 09:04:02,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,PHLEBITIS is location of VARICES,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335493,7/15/2014 20:54:40,,1323836168,7/15/2014 20:54:09,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 20:55:03,,1323836302,7/15/2014 20:54:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 21:05:39,,1323841143,7/15/2014 21:04:47,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,LYME DISEASE causes BORRELIA BURGDORFERI,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 21:34:53,,1323853042,7/15/2014 21:34:00,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,LYME DISEASE causes BORRELIA BURGDORFERI,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 22:37:30,,1323879725,7/15/2014 22:37:02,instagc,0.6089,13763729,USA,"","",75.182.89.225,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 23:46:58,,1323916293,7/15/2014 23:45:58,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/16/2014 00:09:51,,1323929623,7/16/2014 00:09:23,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335494,7/15/2014 21:18:39,,1323846658,7/15/2014 21:18:25,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 00:08:50,,1323928905,7/16/2014 00:08:40,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,BACTERIAL VAGINOSIS treats INTRAVAGINAL 0.75% METRONIDAZOLE GEL,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 06:19:05,,1324082533,7/16/2014 06:18:35,neodev,0.7083,28336203,USA,PA,Harrisburg,50.149.53.150,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 07:28:05,,1324106376,7/16/2014 07:27:30,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 07:52:32,,1324112933,7/16/2014 07:52:13,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 08:35:00,,1324125628,7/16/2014 08:34:37,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335494,7/16/2014 09:29:29,,1324148821,7/16/2014 09:28:58,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,INTRAVAGINAL 0.75% METRONIDAZOLE GEL treats BACTERIAL VAGINOSIS,114,56,,132,92,treats,0.979957887012223,907884-FS1-2,"Hillier SL, Lipinski C, Briselden AM et al. Efficacy of INTRAVAGINAL 0.75% METRONIDAZOLE GEL for the treatment of BACTERIAL VAGINOSIS",BACTERIAL VAGINOSIS,INTRAVAGINAL 0.75% METRONIDAZOLE GEL,RO-may_treat
503335495,7/15/2014 21:01:34,,1323839193,7/15/2014 21:01:28,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,INTRAVASCULAR COAGULATION (DIC treats APL,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/15/2014 22:07:24,,1323865391,7/15/2014 22:06:21,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/16/2014 01:05:23,,1323959735,7/16/2014 01:04:55,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,no_relation,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/16/2014 04:23:40,,1324045403,7/16/2014 04:23:02,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/16/2014 06:24:07,,1324084183,7/16/2014 06:23:53,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,INTRAVASCULAR COAGULATION (DIC treats APL,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/16/2014 07:31:29,,1324107479,7/16/2014 07:30:41,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,no_relation,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335495,7/16/2014 09:30:59,,1324149470,7/16/2014 09:30:27,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,236,297,,265,300,treats,0.78086880944303,902931-FS1-2,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335496,7/15/2014 21:07:28,,1323841938,7/15/2014 21:07:24,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/15/2014 21:20:00,,1323847144,7/15/2014 21:19:28,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/15/2014 21:40:09,,1323854719,7/15/2014 21:39:54,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/16/2014 02:21:21,,1323997713,7/16/2014 02:20:23,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/16/2014 06:22:53,,1324083802,7/16/2014 06:22:39,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/16/2014 07:10:56,,1324100961,7/16/2014 07:10:32,instagc,0.6093,18960682,GBR,"","",86.29.147.112,no_relation,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335496,7/16/2014 08:07:33,,1324117659,7/16/2014 08:07:01,instagc,0.6736,20183814,USA,"","",166.182.83.84,no_relation,62,113,,75,138,causes,0.632455532033676,901625-FS1-4,"However, the presence of a condition associated with reactive THROMBOCYTOSIS does not exclude the possibility of ESSENTIAL THROMBOCYTHEMIA if the first three criteria are met.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335497,7/15/2014 21:04:09,,1323840487,7/15/2014 21:03:07,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:06:57,,1323841772,7/15/2014 21:06:46,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:21:34,,1323847770,7/15/2014 21:21:06,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:56:20,,1323860347,7/15/2014 21:55:41,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 22:00:33,,1323862333,7/15/2014 21:59:34,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 22:27:49,,1323874663,7/15/2014 22:27:35,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/16/2014 01:32:57,,1323975743,7/16/2014 01:32:34,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335498,7/15/2014 20:54:40,,1323836170,7/15/2014 20:54:09,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/15/2014 21:06:22,,1323841493,7/15/2014 21:05:40,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/15/2014 21:33:31,,1323852659,7/15/2014 21:33:15,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/16/2014 01:24:41,,1323971730,7/16/2014 01:24:35,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/16/2014 01:31:59,,1323975332,7/16/2014 01:31:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/16/2014 01:38:13,,1323977665,7/16/2014 01:37:50,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,FUNGUS causes FUNGAL INFECTION,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335498,7/16/2014 02:20:22,,1323997342,7/16/2014 02:20:06,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,100,130,,105,146,causes,0.975900072948533,903937-FS1-4,"rhinophycomycosis    (                         audio )  [&dblprime; +  phykos , seaweed, +  mykes , FUNGUS +  osis , condition] A FUNGAL INFECTION that may occur in humans or animals.",FUNGUS,FUNGAL INFECTION,RO-has_causative_agent
503335499,7/15/2014 21:07:19,,1323841865,7/15/2014 21:07:15,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/15/2014 21:07:53,,1323842131,7/15/2014 21:07:08,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,CUTANEOUS VESSEL VASODILATION causes BLOOD FLOW INCREASED,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/15/2014 21:24:24,,1323849086,7/15/2014 21:24:05,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,CUTANEOUS VESSEL VASODILATION causes BLOOD FLOW INCREASED,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/15/2014 21:44:29,,1323856166,7/15/2014 21:43:37,clixsense,0.6875,19638651,USA,"","",173.23.121.63,CUTANEOUS VESSEL VASODILATION causes BLOOD FLOW INCREASED,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/15/2014 22:27:25,,1323874509,7/15/2014 22:27:14,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,CUTANEOUS VESSEL VASODILATION causes BLOOD FLOW INCREASED,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/16/2014 02:26:36,,1323999906,7/16/2014 02:26:24,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,no_relation,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335499,7/16/2014 02:28:05,,1324000477,7/16/2014 02:27:34,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,CUTANEOUS VESSEL VASODILATION causes BLOOD FLOW INCREASED,95,69,,123,89,causes,0.959403223600247,905157-FS1-4,Hoku acupuncture also increased palm temperature suggesting that the BLOOD FLOW INCREASED from CUTANEOUS VESSEL VASODILATION.,CUTANEOUS VESSEL VASODILATION,BLOOD FLOW INCREASED,RO-has_finding_site
503335500,7/15/2014 21:59:33,,1323861815,7/15/2014 21:58:36,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 00:32:26,,1323942297,7/16/2014 00:31:38,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 02:25:20,,1323999381,7/16/2014 02:24:28,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 06:16:27,,1324081584,7/16/2014 06:16:01,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 07:10:56,,1324100979,7/16/2014 07:10:32,instagc,0.6093,18960682,GBR,"","",86.29.147.112,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 07:28:59,,1324106780,7/16/2014 07:28:06,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 10:29:23,,1324184326,7/16/2014 10:28:34,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,AGENTS (ATROPINE diagnosed by ARREST ARRHYTHMIA,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335501,7/15/2014 21:23:53,,1323848891,7/15/2014 21:23:38,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/15/2014 21:33:31,,1323852658,7/15/2014 21:33:15,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/16/2014 00:31:14,,1323941745,7/16/2014 00:30:30,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/16/2014 01:24:34,,1323971655,7/16/2014 01:24:29,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/16/2014 01:38:13,,1323977666,7/16/2014 01:37:50,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/16/2014 08:05:51,,1324117160,7/16/2014 08:05:12,instagc,0.6736,20183814,USA,"","",166.182.83.84,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335501,7/16/2014 08:35:28,,1324125741,7/16/2014 08:35:02,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,SKIN is location of LICHENOID ERUPTION,32,59,,35,77,is location of,0.768349819927832,905296-FS1-9,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335502,7/16/2014 02:28:36,,1324000761,7/16/2014 02:28:08,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 02:53:36,,1324008901,7/16/2014 02:52:48,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,CHRONIC NEUROGENIC BLADDERS causes PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 07:28:05,,1324106375,7/16/2014 07:27:30,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,no_relation,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 09:04:01,,1324133654,7/16/2014 09:03:56,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE causes CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 10:33:17,,1324185685,7/16/2014 10:32:33,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 10:56:45,,1324196268,7/16/2014 10:55:51,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE causes CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 11:29:10,,1324207285,7/16/2014 11:28:41,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,126,211,,152,251,causes,0.457495710997814,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335503,7/15/2014 21:04:09,,1323840490,7/15/2014 21:03:07,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,TIMOLOL treats MYOCARDIAL INFARCTION,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/15/2014 21:06:15,,1323841463,7/15/2014 21:06:01,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,TIMOLOL treats MYOCARDIAL INFARCTION,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/15/2014 22:08:57,,1323866134,7/15/2014 22:08:17,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/15/2014 22:14:06,,1323868327,7/15/2014 22:14:00,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,MYOCARDIAL INFARCTION treats TIMOLOL,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/16/2014 05:06:15,,1324060069,7/16/2014 05:05:50,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/16/2014 06:23:10,,1324083902,7/16/2014 06:22:54,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,MYOCARDIAL INFARCTION treats TIMOLOL,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335503,7/16/2014 07:09:38,,1324100464,7/16/2014 07:09:23,instagc,0.6093,18960682,GBR,"","",86.29.147.112,TIMOLOL treats MYOCARDIAL INFARCTION,49,35,,69,42,treats,0.666666666666667,907627-FS1-2,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335504,7/15/2014 20:54:32,,1323836090,7/15/2014 20:54:01,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,MICRONUTRIENT DEFICITS causes PROTEIN CALORIE MALNUTRITION,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/15/2014 21:18:42,,1323846675,7/15/2014 21:18:24,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,MICRONUTRIENT DEFICITS causes PROTEIN CALORIE MALNUTRITION,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/15/2014 21:21:34,,1323847771,7/15/2014 21:21:06,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,PROTEIN CALORIE MALNUTRITION causes MICRONUTRIENT DEFICITS,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/15/2014 21:59:47,,1323861945,7/15/2014 21:59:17,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,MICRONUTRIENT DEFICITS causes PROTEIN CALORIE MALNUTRITION,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/15/2014 23:29:47,,1323907501,7/15/2014 23:29:04,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,MICRONUTRIENT DEFICITS causes PROTEIN CALORIE MALNUTRITION,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/16/2014 01:32:57,,1323975741,7/16/2014 01:32:34,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,PROTEIN CALORIE MALNUTRITION causes MICRONUTRIENT DEFICITS,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335504,7/16/2014 02:17:34,,1323996068,7/16/2014 02:17:30,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,MICRONUTRIENT DEFICITS causes PROTEIN CALORIE MALNUTRITION,101,30,,128,52,causes,0.990147542976674,900167-FS1-4,Selective food intake induced MICRONUTRIENT DEFICITS (moderate undernutrition) and can later lead to PROTEIN CALORIE MALNUTRITION (PCM.,PROTEIN CALORIE MALNUTRITION,MICRONUTRIENT DEFICITS,RO-cause_of
503335505,7/15/2014 20:55:26,,1323836447,7/15/2014 20:55:05,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,ESSENTIAL THROMBOCYTHEMIA diagnosed by THROMBOCYTOSIS,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/15/2014 21:14:27,,1323845010,7/15/2014 21:14:06,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,ESSENTIAL THROMBOCYTHEMIA diagnosed by THROMBOCYTOSIS,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/15/2014 21:31:11,,1323851833,7/15/2014 21:30:48,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,no_relation,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/15/2014 21:58:35,,1323861278,7/15/2014 21:57:38,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,THROMBOCYTOSIS diagnosed by ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/15/2014 22:15:15,,1323868908,7/15/2014 22:15:00,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,THROMBOCYTOSIS diagnosed by ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/16/2014 01:04:23,,1323959136,7/16/2014 01:03:19,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,no_relation,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335505,7/16/2014 02:20:05,,1323997238,7/16/2014 02:19:48,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,100,156,,113,181,diagnosed by,0.381000381000572,901650-FS1-13,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335506,7/15/2014 22:09:59,,1323866605,7/15/2014 22:09:32,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,FOSPHENYTOIN treats STATUS EPILEPTICUS,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 02:35:15,,1324003097,7/16/2014 02:34:12,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 04:23:01,,1324045157,7/16/2014 04:22:19,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,FOSPHENYTOIN treats STATUS EPILEPTICUS,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 08:06:29,,1324117340,7/16/2014 08:05:53,instagc,0.6736,20183814,USA,"","",166.182.83.84,FOSPHENYTOIN treats STATUS EPILEPTICUS,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 08:25:44,,1324123188,7/16/2014 08:24:41,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,FOSPHENYTOIN treats STATUS EPILEPTICUS,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 11:28:06,,1324206945,7/16/2014 11:27:14,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335506,7/16/2014 11:48:44,,1324214123,7/16/2014 11:48:03,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,FOSPHENYTOIN treats STATUS EPILEPTICUS,44,0,,61,12,treats,0.962250448649376,907563-FS1-2,FOSPHENYTOIN and phenytoin in patients with STATUS EPILEPTICUS: improved tolerability versus increased costs.,STATUS EPILEPTICUS,FOSPHENYTOIN,RO-may_treat
503335507,7/15/2014 20:56:29,,1323836849,7/15/2014 20:55:28,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,no_relation,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 21:18:39,,1323846656,7/15/2014 21:18:25,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 21:20:38,,1323847424,7/15/2014 21:20:02,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 22:27:34,,1323874567,7/15/2014 22:27:26,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 00:40:05,,1323945878,7/16/2014 00:39:20,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 01:05:23,,1323959739,7/16/2014 01:04:55,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 05:08:20,,1324060832,7/16/2014 05:07:43,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335508,7/15/2014 21:45:52,,1323856671,7/15/2014 21:45:22,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/15/2014 21:57:35,,1323860854,7/15/2014 21:57:03,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 00:33:32,,1323942789,7/16/2014 00:33:19,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 06:16:27,,1324081581,7/16/2014 06:16:01,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 07:52:59,,1324113024,7/16/2014 07:52:34,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,OF RADIATION INDUCED THYROID CANCER causes EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 09:32:05,,1324150102,7/16/2014 09:31:39,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 10:34:37,,1324186106,7/16/2014 10:34:09,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,EVEN WHEN THE THYROID GLAND IS OUTSIDE OF causes OF RADIATION INDUCED THYROID CANCER,121,85,,161,120,causes,0.685994340570035,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335509,7/15/2014 21:24:12,,1323849010,7/15/2014 21:23:54,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,PTLD diagnosed by LYMPHADENOPATHY,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 01:38:45,,1323977910,7/16/2014 01:38:14,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,LYMPHADENOPATHY diagnosed by PTLD,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 07:11:11,,1324101114,7/16/2014 07:10:57,instagc,0.6093,18960682,GBR,"","",86.29.147.112,no_relation,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 08:07:00,,1324117515,7/16/2014 08:06:31,instagc,0.6736,20183814,USA,"","",166.182.83.84,no_relation,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 09:03:55,,1324133633,7/16/2014 09:03:50,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,PTLD diagnosed by LYMPHADENOPATHY,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 09:31:38,,1324149862,7/16/2014 09:31:00,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,LYMPHADENOPATHY diagnosed by PTLD,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335509,7/16/2014 10:32:31,,1324185408,7/16/2014 10:31:44,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,90,52,,104,56,diagnosed by,0.98058067569092,902895-FS1-13,These cases highlight the importance of considering PTLD in the differential diagnosis of LYMPHADENOPATHY and fever post ASCT.,LYMPHADENOPATHY,PTLD,RO-disease_may_have_finding
503335510,7/15/2014 20:53:58,,1323835859,7/15/2014 20:53:25,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/15/2014 21:04:39,,1323840692,7/15/2014 21:03:34,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,ACUTE LUPUS PNEUMONITIS causes SLE,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/15/2014 21:39:03,,1323854413,7/15/2014 21:38:41,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/15/2014 22:14:59,,1323868782,7/15/2014 22:14:40,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,SLE causes ACUTE LUPUS PNEUMONITIS,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/15/2014 23:30:21,,1323907838,7/15/2014 23:29:49,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,ACUTE LUPUS PNEUMONITIS causes SLE,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/16/2014 01:39:36,,1323978173,7/16/2014 01:39:07,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,ACUTE LUPUS PNEUMONITIS causes SLE,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335510,7/16/2014 02:51:57,,1324008363,7/16/2014 02:51:23,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,113,67,,135,70,causes,0.342997170285018,906387-FS1-4,Alveolar hemorrhage occurs in approximately 2% 4% of patients with SLE and may represent part of the spectrum of ACUTE LUPUS PNEUMONITIS (tvml 10tvml ; tvml 32tvml.,ACUTE LUPUS PNEUMONITIS,SLE,RO-has_manifestation
503335511,7/15/2014 20:54:39,,1323836169,7/15/2014 20:53:59,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/15/2014 21:01:27,,1323839142,7/15/2014 21:01:19,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,PAIN causes OSTEOID OSTEOMA,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/15/2014 21:24:58,,1323849341,7/15/2014 21:24:31,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 00:33:17,,1323942668,7/16/2014 00:32:53,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 06:15:25,,1324081207,7/16/2014 06:15:02,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 08:07:33,,1324117662,7/16/2014 08:07:01,instagc,0.6736,20183814,USA,"","",166.182.83.84,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 08:33:53,,1324125399,7/16/2014 08:33:27,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335512,7/15/2014 22:09:31,,1323866376,7/15/2014 22:08:58,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 01:06:46,,1323960519,7/16/2014 01:06:12,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES (MDS),88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 02:17:39,,1323996112,7/16/2014 02:17:35,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES (MDS),88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 04:22:19,,1324044967,7/16/2014 04:21:54,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 05:43:02,,1324071047,7/16/2014 05:42:41,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES (MDS),88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 07:51:22,,1324112520,7/16/2014 07:50:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,MYELODYSPLASTIC SYNDROMES (MDS) causes INEFFECTIVE HEMATOPOIESIS,88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335512,7/16/2014 08:26:50,,1324123538,7/16/2014 08:25:46,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,MYELODYSPLASTIC SYNDROMES (MDS) causes INEFFECTIVE HEMATOPOIESIS,88,4,,112,35,causes,0.975900072948533,901915-FS1-4,The MYELODYSPLASTIC SYNDROMES (MDS) are a family of disorders that are characterized by INEFFECTIVE HEMATOPOIESIS and evolution to acute myelogenous leukemias (AMLs) that are strikingly refractory to current therapeutic approaches.,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES (MDS),RO-disease_has_finding
503335513,7/15/2014 20:55:25,,1323836439,7/15/2014 20:54:41,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/15/2014 21:14:04,,1323844818,7/15/2014 21:13:34,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,APL causes INTRAVASCULAR COAGULATION (DIC,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 00:10:32,,1323930132,7/16/2014 00:09:58,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,INTRAVASCULAR COAGULATION (DIC causes APL,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 05:41:43,,1324070716,7/16/2014 05:41:06,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,INTRAVASCULAR COAGULATION (DIC causes APL,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 09:04:21,,1324133784,7/16/2014 09:04:16,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,APL causes INTRAVASCULAR COAGULATION (DIC,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 10:34:07,,1324185942,7/16/2014 10:33:19,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 11:31:19,,1324208012,7/16/2014 11:31:01,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335514,7/15/2014 21:23:37,,1323848769,7/15/2014 21:23:15,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,SCHIZOPHRENIA treats OLANZAPINE,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/15/2014 23:46:58,,1323916282,7/15/2014 23:45:58,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/16/2014 02:48:54,,1324007525,7/16/2014 02:48:21,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/16/2014 06:15:40,,1324081294,7/16/2014 06:15:26,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/16/2014 07:30:15,,1324107170,7/16/2014 07:29:34,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/16/2014 08:07:45,,1324117701,7/16/2014 08:07:34,instagc,0.6736,20183814,USA,"","",166.182.83.84,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335514,7/16/2014 08:36:09,,1324125897,7/16/2014 08:35:29,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,OLANZAPINE treats SCHIZOPHRENIA,253,286,,265,296,treats,0.970494958830946,907749-FS1-2,severe mental illness (Cochrane Review)  Risperidone versus other atypical antipsychotic medication for schizophrenia (Cochrane Review)  Perazine for schizophrenia (Cochrane Review)  Benperidol for schizophrenia (Cochrane Review)  Depot risperidone for SCHIZOPHRENIA (Cochrane Review)  OLANZAPINE for schizophrenia (Cochrane Review)  Antipsychotic medication for those with both schizophrenia and learning disability (Cochrane Review)  Electroconvulsive therapy for schizophrenia (Cochrane Review)  Beta blocker supplementation of standard drug treatment for schizophrenia (Cochrane Review)  Depot fluphenazine for schizophrenia (Cochrane Review)  Carbamazepine for schizophrenia and schizoaffective psychoses (Cochrane.,SCHIZOPHRENIA,OLANZAPINE,RO-may_treat
503335515,7/15/2014 20:55:03,,1323836306,7/15/2014 20:54:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/15/2014 21:01:34,,1323839198,7/15/2014 21:01:28,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/15/2014 21:27:23,,1323850379,7/15/2014 21:26:29,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/15/2014 22:03:15,,1323863552,7/15/2014 22:02:17,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/16/2014 01:31:21,,1323975093,7/16/2014 01:30:35,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/16/2014 02:25:42,,1323999547,7/16/2014 02:25:29,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335515,7/16/2014 02:48:15,,1324007287,7/16/2014 02:47:30,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,COBALAMIN DEFICIENCY causes SUBACUTE COMBINED DEGENERATION OF THE SPINAL,74,39,,117,59,causes,0.979795897113271,900320-FS1-4,We describe a patient with unsuspected COBALAMIN DEFICIENCY who developed SUBACUTE COMBINED DEGENERATION OF THE SPINAL cord after nitrous oxide anesthesia.,SUBACUTE COMBINED DEGENERATION OF THE SPINAL,COBALAMIN DEFICIENCY,RO-cause_of
503335516,7/15/2014 21:06:27,,1323841544,7/15/2014 21:06:16,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,LOW TURNOVER OSTEOMALACIA causes LOW BONE TURNOVER,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/15/2014 21:25:07,,1323849418,7/15/2014 21:24:25,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,LOW TURNOVER OSTEOMALACIA causes LOW BONE TURNOVER,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/15/2014 21:33:59,,1323852784,7/15/2014 21:33:32,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,LOW TURNOVER OSTEOMALACIA causes LOW BONE TURNOVER,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/15/2014 21:44:29,,1323856167,7/15/2014 21:43:37,clixsense,0.6875,19638651,USA,"","",173.23.121.63,LOW TURNOVER OSTEOMALACIA causes LOW BONE TURNOVER,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/15/2014 22:14:27,,1323868514,7/15/2014 22:14:07,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,LOW BONE TURNOVER causes LOW TURNOVER OSTEOMALACIA,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/16/2014 02:25:20,,1323999380,7/16/2014 02:24:28,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,LOW TURNOVER OSTEOMALACIA causes LOW BONE TURNOVER,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335516,7/16/2014 09:16:22,,1324137930,7/16/2014 09:15:25,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,no_relation,150,181,,166,206,causes,0.949157995752499,902178-FS1-4,"In all centers, independent of the aluminum staining technique used, the extent of aluminum deposited in bone was greater in patients presenting with LOW BONE TURNOVER whether from LOW TURNOVER OSTEOMALACIA or adynamic bone disease, than in the predominant hyperparathyroid bone disease.",LOW BONE TURNOVER,LOW TURNOVER OSTEOMALACIA,RO-disease_has_primary_anatomic_site
503335517,7/15/2014 21:14:04,,1323844817,7/15/2014 21:13:34,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/15/2014 21:20:11,,1323847244,7/15/2014 21:19:40,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/15/2014 21:23:53,,1323848895,7/15/2014 21:23:38,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,VIRUS causes PROOF OF A VIRAL INFECTION OF SHML,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/15/2014 21:45:52,,1323856670,7/15/2014 21:45:22,clixsense,0.6875,19638651,USA,"","",173.23.121.63,no_relation,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/16/2014 02:26:13,,1323999737,7/16/2014 02:26:05,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,no_relation,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/16/2014 02:34:11,,1324002789,7/16/2014 02:33:54,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335517,7/16/2014 07:31:29,,1324107471,7/16/2014 07:30:41,vivatic,0.6569,25451531,GBR,"","",83.67.28.193,VIRUS causes PROOF OF A VIRAL INFECTION OF SHML,2,57,,6,91,causes,0.5,903782-FS1-4,"A VIRUS isolation was not possible, so that the definite PROOF OF A VIRAL INFECTION OF SHML could not be demonstrated.",VIRUS,PROOF OF A VIRAL INFECTION OF SHML,RO-has_causative_agent
503335518,7/15/2014 21:25:07,,1323849416,7/15/2014 21:24:25,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/15/2014 21:25:35,,1323849606,7/15/2014 21:24:59,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/15/2014 22:00:33,,1323862334,7/15/2014 21:59:34,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/16/2014 00:10:47,,1323930332,7/16/2014 00:10:35,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,UTERINE CARCINOSARCOMA contraindicates SARCOMATOUS COMPONENTS,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/16/2014 00:31:36,,1323941909,7/16/2014 00:31:15,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,UTERINE CARCINOSARCOMA contraindicates SARCOMATOUS COMPONENTS,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/16/2014 01:40:16,,1323978441,7/16/2014 01:39:58,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,SARCOMATOUS COMPONENTS contraindicates UTERINE CARCINOSARCOMA,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335518,7/16/2014 02:54:15,,1324009095,7/16/2014 02:53:38,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,168,97,,189,119,contraindicates,0.338061701891407,901637-FS1-10,MMP 7 may contribute to the invasive nature or growth capacity of the carcinomatous component of UTERINE CARCINOSARCOMA while it may not have a relation to that of the SARCOMATOUS COMPONENTS,SARCOMATOUS COMPONENTS,UTERINE CARCINOSARCOMA,RO-disease_has_finding
503335519,7/15/2014 21:30:47,,1323851688,7/15/2014 21:30:33,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,no_relation,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/15/2014 22:27:34,,1323874566,7/15/2014 22:27:26,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,MYOCARDIAL INFARCTION diagnosed by TIMOLOL,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/16/2014 02:34:11,,1324002791,7/16/2014 02:33:54,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/16/2014 02:47:31,,1324007040,7/16/2014 02:46:51,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,TIMOLOL diagnosed by MYOCARDIAL INFARCTION,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/16/2014 04:23:40,,1324045404,7/16/2014 04:23:02,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/16/2014 05:05:50,,1324059944,7/16/2014 05:04:57,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335519,7/16/2014 10:33:17,,1324185692,7/16/2014 10:32:33,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,49,35,,69,42,diagnosed by,0.333333333333333,907627-FS1-13,The Norwegian multicenter study of TIMOLOL after MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,TIMOLOL,RO-may_treat
503335520,7/15/2014 21:05:59,,1323841274,7/15/2014 21:05:44,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/15/2014 21:23:13,,1323848564,7/15/2014 21:22:57,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,CUSHING'S SYNDROME treats AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/15/2014 21:23:48,,1323848856,7/15/2014 21:23:06,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,CUSHING'S SYNDROME treats AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/16/2014 01:06:46,,1323960525,7/16/2014 01:06:12,bitcoinget,0.6514,28377798,GBR,"","",195.166.117.126,no_relation,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/16/2014 02:19:46,,1323997106,7/16/2014 02:19:18,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/16/2014 07:09:57,,1324100601,7/16/2014 07:09:40,instagc,0.6093,18960682,GBR,"","",86.29.147.112,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335520,7/16/2014 09:04:14,,1324133738,7/16/2014 09:04:09,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.639602149066831,906655-FS1-2,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
